Publications are the primary method for reporting and long-term documentation of the research conducted at the NIPER-Hyderabad. Here the list of publications published in year wise...

1. Kumari, P.; Dhane, T. S.; Sathish, M.; Singitham, S.; Shankaraiah, N. Copper(II)-Mediated Regioselective ortho-C–N Bond Formation on Phthalazinones Employing Sulfonamides. ChemistrySelect 2026, 11, e73764. https://doi.org/10.1002/slct.73764
2. Dastari, S.; Shankaraiah, N. Therapeutic Potential of Spirocyclopropyl Oxindoles: Latest Developments in Drug Discovery. Future Medicinal Chemistry 2026, 18, 1753–1767. https://doi.org/10.1080/17568919.2026.2676782
3. Jha, A.; Dastari, S.; Sathish, M.; Shankaraiah, N. NIS-Mediated Olefination of Quinoxalin-2(1H)-ones Using Ketone Derivatives: A Facile Synthetic Access to (Z)-Enaminone Frameworks. Asian Journal of Organic Chemistry 2026, 15, e70463. https://doi.org/10.1002/ajoc.70463
4. Gupta, S.; Ezhilmathe, A.; Galla, M. S.; Godugu, C.; Shankaraiah, N. Copper(II)-Catalyzed One-Pot Synthesis of Thiazole/Benzothiazole-Based Isoquinolin-1(2H)-ones as Potential Cytotoxic and VEGFR-2 Inhibitors. Bioorganic Chemistry 2026, 170, 109506. https://doi.org/10.1016/j.bioorg.2026.109506
5. Singitham, S.; Galla, M. S.; Avvaru, S. J.; Sathish, M.; Kumari, P.; Dikundwar, A. G.; Shankaraiah, N. Visible-Light Mediated One-Pot Synthesis of Pyrazolo[3,4-b]Pyridines via Intramolecular Rearrangement. Asian Journal of Organic Chemistry 2025, 15, e70344. https://doi.org/10.1002/ajoc.70344
6. Kale, N. B.; Galla, M. S.; Shankaraiah, N. Harnessing Functionalized Alkynes in Annulation Reactions: A Comprehensive Review. Asian Journal of Organic Chemistry 2026, 15, e70290. https://doi.org/10.1002/ajoc.70290
7. Dastari, S.; Kopuri, S.; Jha, A.; Avvaru, S. J.; Dikundwar, A. G.; Shankaraiah, N. Metal-Free, Solvent-Controlled Divergent Synthesis of Substituted α-Keto Amides/Benzimidazoquinazolines: DFT, Crystallographic Analysis and in Silico Studies. Journal of Molecular Structure 2026, 1353, 144581. https://doi.org/10.1016/j.molstruc.2025.144581
8. Ramachandran, R. K.; Sasmal, A.; Dhiman, V.; Chaganti, S.; Jagtap, S.; Golla, V. M.; Samanthula, G. Steroidal Saponin Diversity in Costus speciosus Elucidated by Liquid Chromatography–Quadrupole Time-of-Flight Tandem Mass Spectrometry Coupled with Feature-Based Molecular Networking. Journal of Analytical Chemistry 2026, 81 (1), 115–126. https://doi.org/10.1134/S1061934825701436
9. Pimpre, K.; Chaganti, S.; Khemchandani, R.; Pilli, P.; Kommalapati, H.; Samanthula, G. Integrative Study on Triclabendazole Stability: Forced Degradation and In Silico Toxicity Prediction of Degradation Products. Biomedical Chromatography 2026, 40 (2), e70331. https://doi.org/10.1002/bmc.70331
10. Prasad, S. V.; Rahaman, S. A.; Samanthula, G.; Lankalapalli, S. P.; Pilli, P. Separation and Characterization of Degradation Impurities of Voxelotor by Liquid Chromatography and High Resolution Mass Spectrometry. Separation Science Plus 2026, 9 (2), e70192. https://doi.org/10.1002/sscp.70192
11. Shaikh, N.; Chaganti, S.; Khemchandani, R.; Harini, D.; Mouli, H. C.; Samanthula, G. Identification and Structural Characterization of Degradation Products of Tivozanib Using LC-Q-TOF-MS/MS and NMR: An In Silico Approach for Degradation and Toxicity Prediction. Rapid Communications in Mass Spectrometry 2026, 40 (3), e10167. https://doi.org/10.1002/rcm.10167
12. Harini, D.; Mouli, H. C.; Raman, P. K.; Singh, N.; Shreya, S.; Khemchandani, R.; Shaikh, N.; Godugu, C.; Samanthula, G. Phytoconstituents of Gmelina Arborea as Potential Breast Cancer Inhibitors: LC-MS/MS, Docking, MD Simulations, and In Vitro Evaluation. Chemistry & Biodiversity 2026, 23 (3), e01930. https://doi.org/10.1002/cbdv.202501930
13. Shaikh, N.; Khemchandani, R.; Shevatkar, J.; Samanthula, G. Characterization of forced degradation products of tyrosine kinase inhibitor apatinib mesylate by LC-MS/MS and NMR with in silico toxicity assessment. Journal of Pharmaceutical and Biomedical Analysis 2026, 117492. https://doi.org/10.1016/j.jpba.2026.117492
14. Pilli, P.; Golla, V. M.; Chaganti, S.; Barik, P.; Kommalapati, H. S.; Pimpre, K.; Samanthula, G. Comprehensive Forced Degradation Study of Pemigatinib and Structural Elucidation of Its Degradation Products Using Liquid Chromatography–High-Resolution Mass Spectrometry and Nuclear Magnetic Resonance. Separation Science Plus 2026, 9 (5), e70243. https://doi.org/10.1002/sscp.70243
15. Khemchandani, R.; Pardhi, E.; Jadhav, A.; Shaikh, N.; Bhale, N.; Pilli, P.; Pimpre, K.; Mouli, H. C.; Doijad, N.; Mehra, N. K. Mechanistic enhancement of oral bioavailability through a coamorphous apremilast-aceclofenac systems: integrated LC-MS/MS Bioanalysis, in vivo pharmacokinetics, and PBPK modeling. European Journal of Pharmaceutics and Biopharmaceutics 2026, 115099. https://doi.org/10.1016/j.ejpb.2026.115099
16. Kommalapati, H.; Chaganti, S.; Pilli, P.; Pimpre, K.; Samanthula, G. Simultaneous LC–MS/MS Determination of Primary Leachables from Pharma Receptacles: 2-Mercaptobenzothiazole and 1,3-Diphenylguanidine. Chromatographia 2026, 1–10. https://doi.org/10.1007/s10337-026-04494-z
17. Khemchandani, R.; Pardhi, E.; Faizan, A. M.; Devi, P.; Godugu, C.; Mehra, N. K.; Samanthula, G. Integrated analytical characterization and multiscale modeling of supramolecular interactions in lumefantrine-curcumin coamorphous systems with enhanced biopharmaceutical and anticancer performance. Talanta 2026, 130216. https://doi.org/10.1016/j.talanta.2026.130216
18. Varpe, P.; Dask, T. K.; Srivastava, S.; Nanduri, S. Investigating the Landscape of Personalized Medicine Approvals by the FDA. Journal of Pharmaceutical Innovation 2026, 21. https://doi.org/10.1007/s12247-026-10816-3
19. Gangawane, V. S.; Simran, S.; Kalokhe, V. M.; Musthafa, F.; Ahmad, A.; Godugu, C.; Srivastava, S. Gender Representation and Reporting in Post-Marketing Surveillance: A Review of FDA Regulatory Perspectives on Clinical Trials for Parkinson’s Disease. Journal of Pharmaceutical Innovation 2026, 21. https://doi.org/10.1007/s12247-026-10740-6
20. Mahajan, R.; Shah, S.; Srivastava, S.; Asthana, A.; Samanthula, G. Quality by Design-Assisted Separation and Characterization of Photolytic Degradation Products of Midostaurin Using UHPLC-Q-TOF-MS/MS: In-Silico Prediction and Toxicity Assessment. Rapid Communications in Mass Spectrometry 2026, 40. https://doi.org/10.1002/rcm.70120
21. Singh, A. K.; Kolipaka, T.; Pandey, G.; Wagh, S.; Samadder, B.; Srivastava, S. Harnessing Polysaccharide-Based Approaches for Posterior Ocular Disorders: Therapeutic Applications, Regulatory Perspectives, Challenges, and Future Directions. Journal of Drug Delivery Science and Technology 2026, 123, 108472. https://doi.org/10.1016/j.jddst.2026.108472
22. Devi, A.; Phatale, V.; Shukla, S.; Shetty, P.; Srivastava, A.; Chaure, P.; Khairnar, P.; Srivastava, S. From Oceanic Depths to Oncology Frontlines: Fucoidan as a Marine-Forged Bioactive Agent Targeting Non-Small Cell Lung Cancer. Food Bioscience 2026, 82, 109461. https://doi.org/10.1016/j.fbio.2026.109461
23. Sahane, P.; Khairnar, P.; Vambhurkar, G.; Phatale, V.; Kumar, R.; Srivastava, S. QbD-Guided Development and In Silico, In Vitro, Ex Vivo, and In Vivo Dermatokinetic Evaluation of a Fluvastatin-Loaded Transferosomal Hydrogel for the Management of Melanoma. Biomaterials Advances 2026, 188, 215046. https://doi.org/10.1016/j.bioadv.2026.215046
24. Hedaoo, A.; Khairnar, P.; Vambhurkar, G.; Sahane, P.; Kumar, R.; Sharma, A.; Sharma, A.; Srivastava, S. Quality by Design-Endorsed Nilotinib-Laden Liposomal Gel for Enhanced Dermal Delivery in Melanoma Management: Fabrication, Optimization, In Silico, In Vitro, and Ex Vivo Studies. ACS Applied Bio Materials 2026. https://doi.org/10.1021/acsabm.5c01778
25. Famta, P.; Vambhurkar, G.; Pandey, G.; Wagh, S.; Sharma, A.; Pandia, C.; Samadder, B.; Srivastava, S. Repurposing Statins for the Management of Head and Neck Squamous Cell Carcinoma: A Systematic Review of Preclinical and Clinical Evidence. Medical Oncology 2026, 43. https://doi.org/10.1007/s12032-026-03302-w
26. Amulya, E.; Kumari, D.; Kumar, R.; Vambhurkar, G.; Dandekar, M. P.; Srivastava, S. Nose-to-Brain Delivery of Riluzole-Loaded Nanoemulsion in a Controlled Cortical Impact-Induced Traumatic Brain Injury: Insights from In Vitro, Ex Vivo, and In Vivo Studies. Colloids and Surfaces B: Biointerfaces 2026, 267, 115955. https://doi.org/10.1016/j.colsurfb.2026.115955
27. Joga, R.; Vambhurkar, G.; Pilli, P.; Kumar, R.; Siragam, S.; Samanthula, G.; Srivastava, S. Regulatory Science-Aligned Development and Multivariate Optimisation of a Lidocaine-Laden Novel Nanoemulgel for the Topical Management of Imiquimod-Induced Psoriasis in BALB/c Mice. Journal of Drug Delivery Science and Technology 2026, 124, 108601. https://doi.org/10.1016/j.jddst.2026.108601
28. Sreya, R.; Nene, S.; Pathade, V.; Vambhurkar, G.; Phatale, V.; Srivastava, S. Ruxolitinib Phosphate-Laden Nanoemulgel: Amelioration of Ex Vivo Permeation and In Vivo Therapeutic Efficacy for the Effective Therapeutic Management of Psoriasis. Inflammopharmacology 2026. https://doi.org/10.1007/s10787-026-02286-3
29. Sikder, A.; Naresh Katarpawar, S.; Kumar, R.; Phatale, V.; Vambhurkar, G.; Pandey, G.; Wagh, S.; Sharma, A.; Amulya, E.; Khairnar, P.; Dikundwar, A. G.; Srivastava, S. QbD-Based Intranasal pH-Sensitive Ibrutinib Liposomes for Glioblastoma Management: In Vitro, Ex Vivo, and In Vivo Pharmacokinetics and Brain Distribution Assessment. European Journal of Pharmaceutics and Biopharmaceutics 2026, 225, 115121. https://doi.org/10.1016/j.ejpb.2026.115121
30. Simran, S.; Thakur, A.; Ahire, A. K.; Srivastava, S.; Asthana, A. Evaluating Regulatory Oversight through Major In Vitro Diagnostic Recalls: A Retrospective Study of FDA Data (2015–2024). Expert Review of Medical Devices 2026, 23, 723–731. https://doi.org/10.1080/17434440.2026.2669127
31. Shende, P.; Joga, R.; Yerram, S.; Gandhi, K.; Sowndharya, M.; Srivastava, S. Delving into the Regulations, Policies, Legislation, and Diversified Strategies across the US & Europe for Tackling Antimicrobial Resistance. Journal of Pharmaceutical Innovation 2026, 21. https://doi.org/10.1007/s12247-026-10486-1
32. Wagh, S.; Famta, P.; Shah, S.; Vambhurkar, G.; Kumar, R.; Sharma, A.; Pandey, G.; Singh, G.; Khairnar, P.; Sikder, A.; Sharma, A.; Shinde, S.; Pandia, C.; Samadder, B.; Kalia, N. P.; Srivastava, S. Quality by Design Manoeuvred Cabazitaxel-Loaded Polycaprolactone Nanoparticles for Management of Melanoma: Development, Optimization, In Silico Modeling and In Vitro Studies. Journal of Cluster Science 2026, 37. https://doi.org/10.1007/s10876-026-03026-x
33. Kaur, J.; Famta, P.; Srivastava, S.; Thakur, G.; Awasthi, A.; Singh, S. K. RNAi-Loaded Exosomes for the Management of Breast Cancer: Emerging Paradigms in Precision Therapy. Advanced Biology 2026, 10. https://doi.org/10.1002/adbi.70127
34. Gadekar, K. V.; Joga, R.; Yerram, S.; Waiker, S.; Srivastava, S. A Five-Year Trend Analysis of USFDA Expedited Approvals and Designations for New Drug Applications (2020–2024). Journal of Pharmaceutical Innovation 2026, 21. https://doi.org/10.1007/s12247-026-10399-z
35. Vijay, G. K.; Joga, R.; Yerram, S.; Waiker, S.; Gandhi, K.; M, S.; Srivastava, S. Psychedelics in Focus: Clinical Trial Advancements, USFDA Breakthrough Designations, Innovative Approaches, Legal and Regulatory Aspects. Journal of Pharmaceutical Innovation 2026, 21. https://doi.org/10.1007/s12247-026-10393-5
36. Kumari, G.; Kundu, S.; Famta, P.; Kalahasti, K. K.; Srivastava, S.; Reddy, G. B.; Srinivasarao, D. A. Core-Shell Nanotherapeutics for Diabetic Cataract and Retinopathy: Current State-of-the-Art and Translational Challenges. Drug Delivery and Translational Research 2026, 16, 1188–1221. https://doi.org/10.1007/s13346-025-01971-0
37. Devi, A.; Singh, S. B.; Srivastava, S.; Dandekar, M. P. Urolithin A Reverses Intranigral Rotenone-Generated Parkinsonism by Modulating DNA Methyltransferase 1 and α-Synuclein Axis in Rats. ACS Chemical Neuroscience 2026, 17, 1611–1629. https://doi.org/10.1021/acschemneuro.5c00362
38. Negi, M.; Amulya, E.; Phatale, V.; Kumar, R.; Srivastava, S. Nose-to-Brain Delivery of Berberine-Loaded Nanoemulsion: Amelioration of Brain Targeting, Behavioral, Pharmacokinetic, and Biodistribution Insights for Alzheimer’s Intervention. Biomaterials Advances 2026, 184, 214835. https://doi.org/10.1016/j.bioadv.2026.214835
39. Pandey, G.; Kolipaka, T.; Yadav, D.; Methri, S. M.; Singh, A. K.; Natesan, S.; Srivastava, S. Next-Generation Polymer-Based Nanofiber Ocular Inserts: Fabrication Innovations, Therapeutic Applications, Regulatory Perspectives, and Future Directions. International Journal of Pharmaceutics 2026, 695, 126781. https://doi.org/10.1016/j.ijpharm.2026.126781
40. Yerram, S.; Muhammad Nizam, V. P.; Srivastava, S.; Nanduri, S. Nitrosamine Contamination in Pharmaceuticals: A Retrospective Regulatory Analysis of USFDA Recalls and Risk Mitigation Strategies (2018–2025). Therapeutic Innovation & Regulatory Science 2026, 60, 519–533. https://doi.org/10.1007/s43441-025-00891-y
41. Patel, P. S.; Pandey, G.; Kumar, A.; Misra, S. K.; Roy, S.; Awasthi, A.; Wagh, S.; Srivastava, S.; Kapoor, A. 3D Bioprinting Employing Hydrogels for Tissue Engineering: Innovations, Challenges, and Regulatory Frontiers. Biomedical Materials & Devices 2026. https://doi.org/10.1007/s44174-026-00671-8
42. Abraham, N.; Pandey, G.; Kolipaka, T.; Kanaujiya, S.; Arya, D. K.; Kapoor, D. D.; Gupta, R. K.; Rajinikanth, P. S.; Srivastava, S. Multifunctional Bilayered Nanofibrous Scaffold of Chitosan/Poly(caprolactone) Enriched with Simvastatin and Thymoquinone for Accelerated Diabetic Wound Healing. International Journal of Biological Macromolecules 2026, 353, 151109. https://doi.org/10.1016/j.ijbiomac.2026.151109
43. Kolipaka, T.; Pandey, G.; Amulya, E.; Singh, A. K.; Srinivasarao, D. A.; Srivastava, S. Innovative siRNA Strategies: Scaling New Horizons in Diabetic Foot Ulcer Therapeutics. Bionanoscience 2026, 16. https://doi.org/10.1007/s12668-025-02389-1
44. Sowndharya, M.; Joga, R.; Yerram, S.; Gandhi, K.; Waiker, S.; Vijay, G. K.; Srivastava, S. Exploring the Role and Trends of USFDA’s Efficacy Supplement Approvals for NDA in Fulfilling Unmet Medical Needs in Healthcare (2019–2023). Journal of Pharmaceutical Innovation 2026, 21. https://doi.org/10.1007/s12247-025-10208-z
45. Shukla, S.; Phatale, V.; Khairnar, P.; Puri, N.; Sahane, P.; Wagh, S.; Sharma, A.; Srinivasarao, D. A.; Srivastava, S. Emerging Metallic Nanoparticle Modalities in Oral Squamous Cell Carcinoma: A Comprehensive Review on Theranostic Strategies and Future Perspectives. ACS Applied Bio Materials 2026, 9, 529–572. https://doi.org/10.1021/acsabm.5c01714
46. Jain, A.; Pandey, G.; Kolipaka, T.; Sharma, A.; Arya, D. K.; Rajinikanth, P. S.; Srivastava, S. Electrospun Poly(vinyl alcohol)/Zein-Based Nanofibrous Dressings Co-Loaded with Pramipexole and Hesperidin for Diabetic Wound Management: In Silico, In Vitro, and In Vivo Assessments. International Journal of Biological Macromolecules 2026, 340, 150092. https://doi.org/10.1016/j.ijbiomac.2026.150092
47. Kaur, J.; Famta, P.; Srivastava, S.; Awasthi, A.; Singh, T. G.; Pal, S.; Charu; Singh, S. K. Ginger Pharmacology from Tradition to Innovation: Modern Clinical Relevance and Nanotherapeutics. Journal of the Science of Food and Agriculture 2026, 106, 5751–5774. https://doi.org/10.1002/jsfa.70468
48. Bhale, N. A.; Subha Jahnavi, A.; Khemchandani, R.; Vambhurkar, G.; Suradkar, R. V.; Shah, S.; Patel, R.; Doijad, N. S.; Samanthula, G.; Srivastava, S.; Dikundwar, A. G. Drug–Drug Coamorphous System of Tadalafil and Finasteride for Enhanced Pharmaceutical Performance. Molecular Pharmaceutics 2026, 23, 127–138. https://doi.org/10.1021/acs.molpharmaceut.5c00513
49. Bhalerao, H. A.; Dhurjad, P.; Bharate, A.; Sonti, R. A Single Bioanalytical LC-MS/MS Method for the Quantification of Pelitinib Across Biological Matrices: An Insight into In Vitro Metabolic Stability and In Vivo Pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis 2026, 280, 117622. https://doi.org/10.1016/j.jpba.2026.117622
50. Yadav, R.; Chary, P. S.; Bhalerao, H. A.; Sonti, R.; Mehra, N. K. Development, Validation and Application of LC-MS/MS Method for Simultaneous Determination of Irinotecan and Cyclosporine in Co-Loaded Self-Nanoemulsifying Drug Delivery System. Annales Pharmaceutiques Françaises 2026. https://doi.org/10.1016/j.pharma.2026.05.007
51. Talari, S.; Nelwade, P. T.; Sonti, R. Isolation and Structural Characterisation of the Degradation Products of Tazemetostat Hydrobromide, an FDA-Approved EZH2 Inhibitor: Evidence for Two Distinct N-Oxidation Pathways. Journal of Molecular Structure 2026, 1366, 146071. https://doi.org/10.1016/j.molstruc.2026.146071
52. Dhannura, S.; Vijayasarathy, M.; Patil, K.; Manjunath, B.; Sonti, R.; Revanasiddappa, P. D.; Gowd, K. H. Site-Specific Post-Translational Modifications Regulate the Binding Affinity of Conus amadis α-Conotoxin Am2005 to Ac-AChBP. Journal of Biomolecular Structure and Dynamics 2026, 1–21. https://doi.org/10.1080/07391102.2026.2648676
53. Mukhopadhyay, N.; Satti, S.; Sen, S.; Kumar, A.; Sandbhor, R.; Dikundwar, A. G.; Kaki, V. R.; Dandekar, M. P. Elucidation of Potential Anti-Inflammatory Targets of Machilus macrantha (Gulmavu) by Utilizing GC–MS, Network Pharmacological Analysis, and Experimental Validation. Journal of Pharmaceutical Innovation 2026, 21, 173. https://doi.org/10.1007/s12247-026-10389-1
54. Mukhopadhyay, N.; Satti, S.; Sen, S.; Kumar, A.; Sandbhor, R.; Dikundwar, A. G.; Dandekar, M. P.; Kaki, V. R. Exploring the Potential Targets and Elucidating the Molecular Mechanisms Underlying the Anti-inflammatory Activity of Plectranthus amboinicus (Karpuravalli) in the Arachidonic Acid Metabolic Pathway by Network Pharmacology, Molecular Docking and Experimental Validation. Journal of Computational Biophysics and Chemistry 2026, 25 (11), 2325–2349.
55. P. Repurposed anticancer drugs disrupt cancer-like traits of Theileria annulata and suppress Leishmania donovani. Lareb S, Subudhi M, Suresh A, V Bhandari, Brahma U, Sharma S. Cell Communication and Signaling: CCS. 2026 Jul 13. https://doi.org/10.1186/s12964-026-02992-z
56. Targeting cyclic di-AMP signaling through diadenylate cyclase inhibition reduces methicillin resistance in clinical MRSA isolates. Kumari N, Jali I, Garg P, Ayanna R, Bhaskar V, V Bhandari, Sharma S, Dey B. Current Research in Microbial Sciences. 2026 May 25:100615. https://doi.org/10.1016/j.crmicr.2026.100615
57. Therapeutic relevance of NLPA Lipoprotein to combat biofilm-associated infections in Acinetobacter baumannii. Brahma U, Munagalasetty S, & V Bhandari. 2026. https://doi.org/10.64898/2026.05.18.725845
58. Harnessing plant-derived bioactive compounds as LOX-1 inhibitors in Helicobacter pylori-driven gastric inflammation. Toxicology and Applied Pharmacology (2026): 117867. Njini Nfor Gael, Siddharth Singh, Harshita Shrivastava, Divyasree Vulli, Sakshi Subhash Kale, Lauve Rachel Tchokouaha Yamthe, Cedric Tchinda Fossi, Vasundhra Bhandari, and Hem Chandra Jha. https://doi.org/10.1016/j.taap.2026.117867
59. Targeting Peptidoglycan Biosynthesis in Methicillin-Resistant Staphylococcus aureus. In Silico Research in Biomedicine (2026): 100331. Kar A, Vemula D, and Vasundhra Bhandari. https://doi.org/10.1016/j.insi.2026.100331
60. Disulfiram Attenuates Acinetobacter baumannii-Induced Hyperinflammation by Regulating Inflammatory Pathways: Insights from RNA Sequencing. ACS Infectious Diseases 12, no. 4 (2026): 1279-1288. Vulli D, Singothu S, Kinkar D, Kumar R, Bandaru RK, and Vasundhra Bhandari. https://doi.org/10.1021/acsinfecdis.5c00902
61. Human serum albumin-based polymeric nanoparticles for ratiometric co-encapsulation and co-delivery of palbociclib and tamoxifen citrate for synergistic effect in breast cancer management. International Journal of Biological Macromolecules. 2026 Mar 14:151448. Gupta U, Sonone PR, Sharma A, Mungalasetty S, Yadav P, Bharath M, V Bhandari, Chourasia MK, Singh PK. https://doi.org/10.1016/j.ijbiomac.2026.151448
62. Design, synthesis and antibacterial evaluation of piperazine urea–pyrazole-pyrimidine hybrids: in-vitro and in-silico studies. Future Medicinal Chemistry. 2026 Jan 29:1-4. https://doi.org/10.1080/17568919.2026.2619471
63. Stearylamine enriched lipid-polymer hybrid nanoparticles of ursolic acid for targeting Leishmania donovani: In-vitro studies. Glycoscience & Therapy. 2026 Jan 2:100024. Gollapalli S, Bajad G, Brahma U, Chandanapalli DK, Veerabomma H, Loharkar S, Arya S, V Bhandari, Madan J. https://doi.org/10.1016/j.glycos.2025.100024
64. Fabrication of Second-Generation Acalabrutinib Nanocrystals by Employing the Nano-Edge Method for Improving the Physico-Chemical Properties and Forecasting their In-Silico Pharmacokinetic Behaviour. AAPS PharmSciTech 27, no. 1 (2026): 73. Gupta Ujala, Anish Dhuri, Tanmoy Kanp, Khushi Rode, Sharon Munagalasetty, Vasundhra Bhandari, Soumyadip Mukherjee, Arvind Gulbake, and Pankaj Kumar Singh. https://doi.org/10.1208/s12249-025-03298-y
65. Demethoxycurcumin and rosmarinic acid as dual neuroprotective and anti-Epstein-Barr virus glycoprotein 350 agents. Computers in Biology and Medicine 200 (2026): 111383. Rani A, Kumar P, Bagde PH, Singh A, Jaiswal N, Vasundhra Bhandari, Giri R, Parmar HS, and Hem Chandra Jha. https://doi.org/10.1016/j.compbiomed.2025.111383
66. Exploring the Potential Targets and Elucidating the Molecular Mechanisms Underlying the Anti-Inflammatory Activity of Plectranthus amboinicus (Karpuravalli) in the Arachidonic Acid Metabolic Pathway by Network Pharmacology, Molecular Docking, and Experimental Validation. Journal of Computational Biophysics and Chemistry. 2026; 25(11):2325–2349. Mukhopadhyay N, Satti S, Sen S, Kumar A, Sandbhor R, Dikundwar AG, et al. https://doi.org/10.1142/S2737416526500122
67. Development and Validation of RP-HPLC Method for Simultaneous Determination of Decitabine and Repaglinide: Application to Solid Lipid Nanoparticle Formulations with In Vitro Neurotoxicity Assessment. Chromatographia. 2026; 89(1):11–24. Kumari S, Gogikar SK, Dikundwar AG, Dubey SK, and Taliyan R. https://doi.org/10.1007/s10337-025-04453-0
68. Structural and Computational Study of Reversibly Photoswitchable (E)-4-((4-Alkoxyphenyl)diazenyl)benzonitrile-Based Liquid Crystals. CrystEngComm. 2026; 28(2):485–491. Thakur JS, Dash O, Bhale NA, Mondal PK, Dikundwar AG, Polentarutti M, and Nayak SK. https://doi.org/10.1039/d5ce00980d
69. Coamorphous System of Tamoxifen and Curcumin: Tailored Release, Synergism, and Enhanced Pharmacological Outcomes to Combat Breast Cancer. Journal of Drug Delivery Science and Technology. 2026; 108076. Sidhartha NN, Dey S, Chilvery S, Sharma A, Godugu C, and Dikundwar AG. https://doi.org/10.1016/j.jddst.2026.108076
70. Structural, Thermal, and Computational Investigation into Halogen-Bonded Photoresponsive Alkoxy Azo Benzonitrile Derivatives. Crystal Growth & Design. 2026. Thakur JS, Dash O, Bhale NA, Mondal PK, Dikundwar AG, and Nayak SK. https://doi.org/10.1021/acs.cgd.5c01450
71. Tofacitinib Citrate Nanoemulgel Induced Repigmentation in Vitiligo: Assessment of Oxidative Stress, Protein, Immunohistochemistry, and mRNA Expressions. International Journal of Pharmaceutics. 2026; 126719. Veerabomma H, Bhattacharjee S, Goud KS, Kumar J, Chandanapalli DK, Bhale NA, and Madan J. https://doi.org/10.1016/j.ijpharm.2026.126719
72. Visible-Light Mediated One-Pot Synthesis of Pyrazolo[3,4-b]Pyridines via Intramolecular Rearrangement. Asian Journal of Organic Chemistry. 2026; 15(3):e70344. Singitham S, Galla MS, Avvaru SJ, Sathish M, Kumari P, Dikundwar AG, and Shankaraiah N. https://doi.org/10.1002/ajoc.70344
73. Potentially Toxic Metals Contamination in Dietary Supplements: Implications on Human Exposure and Health Risk Assessment. Next Research. 2026; 101613. Patel R, Nallathambi S, Talari K, Bhale NA, and Dikundwar AG. https://doi.org/10.1016/j.nexres.2026.101613
74. Elucidation of Potential Anti-Inflammatory Targets of Machilus macrantha (Gulmavu) by Utilizing GC–MS, Network Pharmacological Analysis, and Experimental Validation. Journal of Pharmaceutical Innovation. 2026; 21(2):173. Mukhopadhyay N, Satti S, Sen S, Kumar A, Sandbhor R, Dikundwar AG, and Dandekar MP. https://doi.org/10.1007/s12247-026-10389-1
75. Molecular Iodine-Enabled Cascade Oxidation and Annulation for the Construction of Polycyclic 5-Aroyl-5,6-dihydropyrazolo[1,5-c]quinazolines. Asian Journal of Organic Chemistry. 2026; 15(4):e70389. Joshi SV, Patil S, Srikanth D, Shaikh AS, Kalam A, Tamang N, and Nanduri S. https://doi.org/10.1002/ajoc.70389
76. Mechanistic Enhancement of Oral Bioavailability through Coamorphous Apremilast–Aceclofenac Systems: Integrated LC–MS/MS Bioanalysis, In Vivo Pharmacokinetics, and PBPK Modeling. European Journal of Pharmaceutics and Biopharmaceutics. 2026; 115099. Khemchandani R, Pardhi E, Jadhav A, Shaikh N, Bhale N, Pilli P, and Samanthula G. https://doi.org/10.1016/j.ejpb.2026.115099
77. QbD-Based Intranasal pH-Sensitive Ibrutinib Liposomes for Glioblastoma Management: In Vitro, Ex Vivo, and In Vivo Pharmacokinetics and Brain Distribution Assessment. European Journal of Pharmaceutics and Biopharmaceutics. 2026; 115121. Sikder A, Katarpawar SN, Kumar R, Phatale V, Vambhurkar G, Pandey G, and Srivastava S. https://doi.org/10.1016/j.ejpb.2026.115121
78. Molecular Dynamics, DFT, and Structural Studies of Acetyl Coumarin Derivatives Targeting Antimicrobial Proteins. Journal of Molecular Structure. 2026; 146825. Reang KT, Suradkar RV, Dikundwar AG, Mondal PK, Deb PK, Venugopala KN, and Nayak SK. https://doi.org/10.1016/j.molstruc.2026.146825
79. Kalam, A., Sahu, N.R., Tamang, N., Harsil, J., Rana, P., Yaddanapudi, V.M. and Nanduri, S. Efforts Toward the Development of an Efficient Synthetic Process for Levetiracetam: An Anti-Epileptic Drug. Chemistry Select 11(34) (2026): e74356. https://doi.org/10.1002/slct.74356
80. Joshi, S.V., Srikanth, D., Kalam, A., Pawar, G., Bhale, N.A., Dikundwar, A.G., Yaddanapudi, V.M. and Nanduri, S. Microwave-Assisted Copper-Mediated One-Pot Sequential Synthesis of Quinolino [3,4-b] quinoxalines. European Journal of Organic Chemistry (2026): e70802. https://doi.org/10.1002/ejoc.70802
81. Varpe, P., Dask, T.K., Srivastava, S., Nanduri, S. Investigating the Landscape of Personalized Medicine Approvals by the FDA. J. Pharm. Innov. 21(6) (2026): 566. https://doi.org/10.1007/s12247-026-10867-6
82. Manasa, V., Jayaprakash, S., Paoletti, N., Srikanth, D., Tamang, N., Soujanya, D., Shaik, M.G., Yaddanapudi, V.M., Supuran, C.T., Nanduri, S. Synthesis and Biological Evaluation of Indole-Benzene Sulfonamides as Carbonic Anhydrase II, IX, and XII Inhibitors. ChemMedChem 21(13) (2026): e70374. https://doi.org/10.1002/cmdc.70374
83. Singampalli, A., Kumar, P., Bandela, R., Devi, A., Nanduri, S., Yaddanapudi, V.M. Expanding the Tetrazole Space: Medicinal Chemistry, Biological Diversity and Structure-Activity Relationships. Future Med. Chem. (2026): 1–19. https://doi.org/10.1080/17568919.2026.2688846
84. Bellapukonda, S.M., KT, M.A., Mishra, S., Kodi, R., Ghosh, S., Korra, L.N., Nanduri, S., Yaddanapudi, V.M. A Comprehensive Review of Indole Hybrids as Anti-Bacterial and Anti-Fungal Agents: Synthetic Protocols and SAR Studies. Future Med. Chem. 18(9) (2026): 1101–1131. https://doi.org/10.1080/17568919.2026.2642582
85. Kumari, D., Ghouse, S.M., Sinha, K., Kalam, A., Singh, K., Nanduri, S. Coumarin Derivatives as New Chemotype Targeting Leishmanial Sterol Biosynthesis Pathway Proteins: An Integrated In Vitro, Mechanistic, and In Silico Evaluation. World J. Microbiol. Biotechnol. 42(5) (2026): 202. https://doi.org/10.1007/s11274-026-04916-y
86. Joshi, S.V., Patil, S., Srikanth, D., Shaikh, A.S., Kalam, A., Tamang, N., Suradkar, R.V., Dikundwar, A.G., Yaddanapudi, V.M., Nanduri, S. Molecular Iodine Enabled Cascade Oxidation and Annulation for the Construction of Polycyclic 5-aroyl-5,6-dihydropyrazolo[1,5-c]Quinazolines. Asian J. Org. Chem. 15(4) (2026): e70389. https://doi.org/10.1002/ajoc.70389
87. Bellapukonda, S.M., Parida, K.K., Bandela, R., Kumar, P., Lahiri, M., Kalia, N.P., Nanduri, S., Yaddanapudi, V.M. Exploration of 1,3-Di Substituted Pyrazole Conjugates as DNA Gyrase Inhibitors to Combat Staphylococcus aureus and Mycobacterium tuberculosis. Bioorg. Chem. 15(174) (2026): 109716. https://doi.org/10.1016/j.bioorg.2026.109716
88. Kumar, P., Singampalli, A., Bandela, R., Bellapukonda, S.M., Kodi, R., Ghosh, S., Korra, L.N., Dalal, A., Devi, A., Kalia, N.P., Nanduri, S., Yaddanapudi, V.M. Structure-Activity Relationship-Driven Lead Optimization of Pyrazole Hydrazide-Hydrazone Analogues as Potent Antimycobacterial Agents: In Vitro and In Silico Studies. Bioorg. Med. Chem. Lett. 136 (2026): 130601. https://doi.org/10.1016/j.bmcl.2026.130601
89. Manasa, V., Ghouse, S.M., Paoletti, N., Sinha, K., Danaboina, S., Tamang, N., Soujanya, D., Yaddanapudi, V.M., Supuran, C.T., Nanduri, S. Exploring Coumarin-Triazole Derivatives as Selective Inhibitors of Carbonic Anhydrase IX and XII. ChemMedChem 21(4) (2026): e202500959. https://doi.org/10.1002/cmdc.202500959
90. Sowjanya Goli; Aditya Teja Guduru; Suman Karadagatla; Errappagari Sreehari; Ira Bhatnagar; Manoj P. Dandekar; Anamika Sharma; Dhiraj Bhatia; Amit Asthana Generation of uniform-sized spheroids as 3D cancer models using simple and scalable PDMS-based microwell devices. 2026. https://doi.org/10.1039/d5ra07878d
91. Sowjanya Goli; Umarani Brahma; Sachin Chandankar; Suman Karadagatla; Anamika Sharma; Vasundhra Bandari; Ira Bhatnagar; Amit Asthana A novel approach for the extraction of nucleic acids using a hybrid paper-plastic device. Talanta 2026. https://doi.org/10.1016/j.talanta.2025.129330
92. Simran Simran; Akash Thakur; Akash Kacharu Ahire; Saurabh Srivastava; Amit Asthana Evaluating regulatory oversight through major in vitro diagnostic recalls: a retrospective study of FDA data (2015–2024). 2026. https://doi.org/10.1080/17434440.2026.2669127
93. Rupali Mahajan; Saurabh Shah; Saurabh Srivastava; Amit Asthana; Gananadhamu Samanthula Quality by Design-Assisted Separation and Characterization of Photolytic Degradation Products of Midostaurin Using UHPLC-Q-TOF-MS/MS: In-Silico Prediction and Toxicity Assessment. 2026. https://doi.org/10.1002/rcm.70120
94. Sowjanya Goli; Umarani Brahma; Sachin Chandankar; Suman Karadagatla; Anamika Sharma; Vasundhra Bandari; Ira Bhatnagar; Amit Asthana A novel approach for the extraction of nucleic acids using a hybrid paper-plastic device. Talanta 2026. https://doi.org/10.1101/2025.09.29.678505
95. Talari Raviteja; Vaishnavi Swetha Varanasi; Dr. B. Lakshmi Social Media Pharma Campaigns and Health-Seeking Behaviour: A Comparative Study of Disease Awareness Vs. Product Promotion Content Among Indian Social Media Users. International Journal of Creative and Open Research in Engineering and Management 2026, 2(7), July 2026. ISSN: 3108-1754.
96. Maramganti Dhatri Deepika; Pradip Kumar Shaw; Dr. B. Lakshmi Impact of digital platforms on patient decision-making across the healthcare journey: an empirical study in urban India. International Journal of Progressive Research in Engineering Management and Science 2026, 6(6), 2322–2343.
97. Manoj Chendke; Rutuja Hivarkar; B. Lakshmi Consumer Trust vs Data Privacy in E-Pharmacies: A Systematic Review of Trade-offs in Digital Healthcare Platforms. International Journal of Pharmaceutical Sciences 2026, 4(6), 3030–3044. DOI: https://doi.org/10.5281/zenodo.20646392
98. Chetan Garg; Sandeep Daravath; Dr. B. Lakshmi Self-Medication Practices Among Young Adults: A Study on Usage Patterns and Reasons. Journal of Advance and Future Research 2026, 4(5), May 2026.
99. Sarthak Devale; Tejasvini Gaykar; Dr. B. Lakshmi A Review of Digital Transformation in Pharmaceutical Marketing: Trends, Opportunities, and Challenges in India. International Journal of Advance Research and Innovative Ideas in Education 2026, 12(3).
100. Ratan Singh; Dhruv Rankesh; Solanki Shahu; Dr. B. Lakshmi Role Of Mobile Health Applications in Improving Medication Adherence in Chronic Disease Management. International Journal of Innovative Research in Technology 2026, 12(12), May 2026.